Marketing-authorisation holder · Spain
Adamed Laboratorios S.L.U.
122 medicines in 1 country, as authorisation holder and marketer.
Loading your page…
Marketing-authorisation holder · Spain
122 medicines in 1 country, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 122
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACOMICIL 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG100 mg · Comprimido recubierto con película | Topiramate | Spain | Marketed | 2008 |
| ACOMICIL 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG200 mg · Comprimido recubierto con película | Topiramate | Spain | Marketed | 2008 |
| ACOMICIL 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG25 mg · Comprimido recubierto con película | Topiramate | Spain | Marketed | 2008 |
| ACOMICIL 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG50 mg · Comprimido recubierto con película | Topiramate | Spain | Marketed | 2008 |
| APIXABAN ADAMED 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG2,5 mg · Comprimido recubierto con película | Apixaban | Spain | Authorised | 2025 |
| APIXABAN ADAMED 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5 mg · Comprimido recubierto con película | Apixaban | Spain | Authorised | 2025 |
| CAMLAD 16 MG/10 MG/12,5 MG CÁPSULAS DURAS16 mg + 13,87 mg + 12,5 mg · Cápsula dura | Candesartan cilexetil, Amlodipine, Hydrochlorothiazide | Spain | Marketed | 2023 |
| CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS16 mg + 6,94 mg + 12,5 mg · Cápsula dura | Candesartan cilexetil, Amlodipine, Hydrochlorothiazide | Spain | Marketed | 2023 |
| COGNEM 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG10 mg · Comprimido recubierto con película | Donepezil | Spain | Marketed | 2012 |
| COGNEM 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5 mg · Comprimido recubierto con película | Donepezil | Spain | Marketed | 2012 |
| DISLAVEN RETARD 150 mg CAPSULAS DE LIBERACION PROLONGADA EFG150 mg · Cápsula dura de liberación prolongada | Venlafaxine | Spain | Marketed | 2007 |
| DISLAVEN RETARD 75 mg CAPSULAS DE LIBERACION PROLONGADA EFG75 mg · Cápsula dura de liberación prolongada | Venlafaxine | Spain | Marketed | 2007 |
| ERIMPOX 2,5 MG CAPSULAS DURAS EFG2,50 mg · Cápsula dura | Apixaban | Spain | Authorised | 2026 |
| ERIMPOX 5 MG CAPSULAS DURAS EFG5 mg · Cápsula dura | Apixaban | Spain | Authorised | 2026 |
| ESLIPIMAD 200 MG COMPRIMIDOS EFG200 mg · Comprimido | Eslicarbazepine | Spain | Authorised | 2021 |
| ESLIPIMAD 400 MG COMPRIMIDOS EFG400 mg · Comprimido | Eslicarbazepine | Spain | Authorised | 2021 |
| ESLIPIMAD 600 MG COMPRIMIDOS EFG600 mg · Comprimido | Eslicarbazepine | Spain | Authorised | 2021 |
| ESLIPIMAD 800 MG COMPRIMIDOS EFG800 mg · Comprimido | Eslicarbazepine | Spain | Authorised | 2021 |
| IMBARIX 10 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA10 mg + 1,5 mg · Comprimido de liberación modificada | Ramipril, Indapamide | Spain | Marketed | 2025 |
| IMBARIX 5 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA5 mg + 1,50 mg · Comprimido de liberación modificada | Ramipril, Indapamide | Spain | Marketed | 2025 |
| MAXON 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG35,125 mg · Comprimido recubierto con película | Sildenafil | Spain | Marketed | 2023 |
| METSUNIX 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA113,38 mg + 1.000 mg · Comprimido de liberación modificada | Sitagliptin, Metformin | Spain | Marketed | 2022 |
| METSUNIX 50 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA56,69 mg + 1.000 mg · Comprimido de liberación modificada | Sitagliptin, Metformin | Spain | Marketed | 2022 |
| METSUNIX 50 MG/500 MG COMPRIMIDOS DE LIBERACION MODIFICADA56,69 mg + 500 mg · Comprimido de liberación modificada | Sitagliptin, Metformin | Spain | Marketed | 2022 |
| NEMEA 100 MG COMPRIMIDOS BUCODISPERSABLES EFG100 mg · Comprimido bucodispersable | Clozapine | Spain | Marketed | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 122 | 111 | 11 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.